PTHS logo

Pelthos Therapeutics Inc.

PTHS
Healthcare|Biotechnology|US
$9.36
+0.06 (+0.65%)
DCF Value
$113.99
Cash / Share
$6.94

Ownership Breakdown

30.7%
Float
3.8M
Shares Outstanding
1.2M
Float Shares

Major Holders (9)

Combined: 106.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Ligand Pharmaceuticals IncorporatedCorporation49.90%5,189,177Nov 3, 202613D/G
3i, LPPartnership9.90%318,886Feb 5, 202613D/G
Marc BistricerHC, IN9.10%280,000Nov 14, 202513D/G
Murchinson Ltd.IA, CO9.10%280,000Nov 14, 202513D/G
Ezra FriedbergIndividual8.30%250,121Jul 3, 202513D/G
Neil ShahrestaniHC, IN7.70%256,598May 15, 202613D/G
Ikarian Capital, LLCInvestment adviser7.70%256,598May 15, 202613D/G
Balmoral Financial Group LLCOther3.10%92,072Jul 3, 202513D/G
Key Recovery Group LLCOther1.30%40,000Jul 3, 202513D/G

Insider Trades (93)

Last 4 quarters: 4,671,387.362 acquired · 171,263 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Greenleaf PeterdirectorOct 2, 2026SELL797$21.17$16.9KForm 4
Friedberg Ezra MdirectorOct 2, 2026SELL558$20.72$11.6KForm 4
Pauls MatthewdirectorOct 2, 2026SELL786$21.00$16.5KForm 4
Friedberg Ezra MdirectorJul 2, 2026SELL534$26.03$13.9KForm 4
Friedberg Ezra MdirectorJul 2, 2026SELL24$27.33$655.81Form 4
Pauls MatthewdirectorJul 2, 2026SELL692$26.00$18.0KForm 4
Pauls MatthewdirectorJul 2, 2026SELL94$27.36$2.6KForm 4
Greenleaf PeterdirectorJul 2, 2026SELL712$26.00$18.5KForm 4
Greenleaf PeterdirectorJul 2, 2026SELL85$27.27$2.3KForm 4
Friedberg Ezra MdirectorJun 15, 2026SELL224$27.12$6.1KForm 4
Friedberg Ezra MdirectorJun 15, 2026SELL59$27.94$1.6KForm 4
Davis Todd CdirectorJun 11, 2026BUY503$28.73$14.4KForm 4
Davis Todd CdirectorJun 11, 2026BUY35,445$27.80$985.5KForm 4
Francis Knuettel IICFO, Treas & SectyMay 22, 2026AWARD59,500$13.50$803.3KForm 4
Francis Knuettel IICFO, Treas & SectyMay 22, 2026DISPOSED13,947——Form 4
Francis Knuettel IICFO, Treas & SectyMay 22, 2026SELL1,500$26.84$40.3KForm 4
Francis Knuettel IICFO, Treas & SectyMay 22, 2026DISPOSED42,500$13.50$573.8KForm 4
Friedberg Ezra MdirectorMay 14, 2026TAX W/H144$27.01$3.9KForm 4
GAY JOHN M.Chief Financial OfficerApr 10, 2026OTHER0——Form 4
GAY JOHN M.Chief Financial OfficerJul 2, 2026OTHER93,000$13.50$1.3MForm 4
Malamut RicharddirectorApr 2, 2026SELL310$20.51$6.4KForm 4
Malamut RicharddirectorApr 2, 2026SELL280$21.36$6.0KForm 4
Friedberg Ezra MdirectorApr 2, 2026SELL293$20.51$6.0KForm 4
Friedberg Ezra MdirectorApr 2, 2026SELL265$21.36$5.7KForm 4
Pauls MatthewdirectorApr 2, 2026SELL415$20.52$8.5KForm 4
Pauls MatthewdirectorApr 2, 2026SELL371$21.36$7.9KForm 4
Greenleaf PeterdirectorApr 2, 2026SELL420$20.52$8.6KForm 4
Greenleaf PeterdirectorApr 2, 2026SELL377$21.36$8.1KForm 4
Friedberg Ezra MdirectorJul 2, 2025AWARD19,108——Form 4
Friedberg Ezra MdirectorNov 13, 2024AWARD2,454——Form 4
Friedberg Ezra MdirectorJun 14, 2024AWARD6,450——Form 4
Davis Todd CdirectorJul 2, 2025AWARD19,108——Form 4
Davis Todd CdirectorNov 13, 2024AWARD4,961——Form 4
Davis Todd CdirectorJun 14, 2024AWARD12,900——Form 4
Malamut RicharddirectorJul 2, 2025AWARD19,108——Form 4
Malamut RicharddirectorNov 13, 2025AWARD2,454——Form 4
Malamut RicharddirectorJun 14, 2024AWARD6,450——Form 4
Plesha Scott M.director, officer: CEO and PresidentJul 2, 2025AWARD83,678——Form 4
Greenleaf PeterdirectorJul 2, 2025AWARD25,478——Form 4
Pauls MatthewdirectorJul 2, 2025AWARD25,478——Form 4
Rangarao SaiChief Commercial OfficerJul 2, 2025AWARD30,518——Form 4
Baxter Richard BdirectorJul 2, 2025AWARD19,108——Form 4
Francis Knuettel IICFO, Treas & SectyJul 2, 2025AWARD33,472——Form 4
Einhorn Andrew J.directorDec 23, 2025AWARD12,000$0.00$1.20Form 4
Einhorn Andrew J.director: Dec 23, 2025OTHER0——Form 4
LIGAND PHARMACEUTICALS INCdirector, 10 percent owner: Dec 17, 2025AWARD0$29.73—Form 4
LIGAND PHARMACEUTICALS INCdirector, 10 percent owner: Dec 17, 2025DISPOSED0$34.44—Form 4
Pauls MatthewdirectorJul 2, 2025OPTION EX.8,493——Form 4
Pauls MatthewdirectorOct 2, 2025OPTION EX.2,123——Form 4
Pauls MatthewdirectorOct 2, 2025OPTION EX.2,123——Form 4
Pauls MatthewdirectorJul 2, 2025OPTION EX.8,493——Form 4
Pauls MatthewdirectorDec 10, 2025GIFT9,542——Form 4
Friedberg Ezra MdirectorNov 25, 2025SELL5,999$28.00$168.0KForm 4
Friedberg Ezra MdirectorNov 25, 2025SELL2,000$28.14$56.3KForm 4
Friedberg Ezra MdirectorNov 25, 2025SELL1$28.50$28.50Form 4
Friedberg Ezra MdirectorNov 25, 2025SELL2,000$28.00$56.0KForm 4
LIGAND PHARMACEUTICALS INCdirector, 10 percent owner: Nov 6, 2025AWARD0$34.44—Form 4
Plesha Scott M.director, officer: CEO and PresidentJul 2, 2025AWARD255,000$13.50$3.4MForm 4
Plesha Scott M.director, officer: CEO and PresidentJul 2, 2025AWARD83,678$13.50$1.1MForm 4
Plesha Scott M.director, officer: CEO and PresidentJul 2, 2025OTHER0——Form 4
Rangarao SaiChief Commercial OfficerJul 2, 2025AWARD93,000$13.50$1.3MForm 4
Rangarao SaiChief Commercial OfficerJul 2, 2025AWARD30,518$13.50$412.0KForm 4
Rangarao SaiofficerJul 2, 2025OTHER0——Form 4
Baxter Richard BdirectorJul 2, 2025AWARD58,230$13.50$786.1KForm 4
Baxter Richard BdirectorJul 2, 2025AWARD19,108$13.50$258.0KForm 4
Greenleaf PeterdirectorJul 2, 2025AWARD77,640$13.50$1.0MForm 4
Greenleaf PeterdirectorJul 2, 2025AWARD25,478$13.50$344.0KForm 4
Pauls MatthewdirectorJul 2, 2025AWARD77,640$13.50$1.0MForm 4
Pauls MatthewdirectorJul 2, 2025AWARD25,478$13.50$344.0KForm 4
Francis Knuettel IICFO, Treas & SectyJul 2, 2025AWARD102,000$13.50$1.4MForm 4
Francis Knuettel IICFO, Treas & SectyJul 2, 2025AWARD33,472$13.50$451.9KForm 4
Davis Todd CdirectorJul 2, 2025AWARD58,230$13.50$786.1KForm 4
Davis Todd CdirectorJul 2, 2025AWARD19,108$13.50$258.0KForm 4
Friedberg Ezra MdirectorJul 2, 2025AWARD58,230$13.50$786.1KForm 4
Friedberg Ezra MdirectorJul 2, 2025AWARD19,108$13.50$258.0KForm 4
Malamut RicharddirectorJul 2, 2025AWARD58,230$13.50$786.1KForm 4
Malamut RicharddirectorJul 2, 2025AWARD19,108$13.50$258.0KForm 4
Greenleaf Peterdirector: Jul 1, 2025OTHER0——Form 4
Pauls Matthewdirector: Jul 1, 2025OTHER0——Form 4
Baxter Richard Bdirector: Jul 1, 2025OTHER0——Form 4
Friedberg Ezra MdirectorJul 1, 2025CONVERSION40,000$10.00$400.0KForm 4
Friedberg Ezra MdirectorJul 1, 2025BUY40,000$10.00$400.0KForm 4
Friedberg Ezra MdirectorJul 1, 2025CONVERSION40,000$10.00$400.0KForm 4
Francis Knuettel IIChief Financial OfficerJul 1, 2025J10,000$10.00$100.0KForm 4
Francis Knuettel IIChief Financial OfficerJul 1, 2025CONVERSION10,000$10.00$100.0KForm 4
Francis Knuettel IIChief Financial OfficerJul 1, 2025CONVERSION10,000$10.00$100.0KForm 4
Davis Todd Cdirector, 10 percent owner: Jul 1, 2025J31,278.681$10.00$312.8KForm 4
Davis Todd Cdirector, 10 percent owner: Jul 1, 2025CONVERSION1,500,000$10.00$15.0MForm 4
Davis Todd Cdirector, 10 percent owner: Jul 1, 2025CONVERSION15,000$10.00$150.0KForm 4
LIGAND PHARMACEUTICALS INC10 percent ownerJul 1, 2025CONVERSION1,500,000$10.00$15.0MForm 4
LIGAND PHARMACEUTICALS INC10 percent ownerJul 1, 2025J31,278.681$10.00$312.8KForm 4
LIGAND PHARMACEUTICALS INC10 percent ownerJul 1, 2025CONVERSION15,000$10.00$150.0KForm 4
LIGAND PHARMACEUTICALS INC10 percent ownerJul 1, 2025OTHER1,800,000$10.00$18.0MForm 4